Gasent Blesa, J. M.; Giner Marco, V.; Giner-Bosch, Vicent; Cerezuela Fuentes, Pablo; Alberola Candel, Vicente(Lippincott Williams & Wilkins, 2011)
[EN] Introduction: Docetaxel plus prednisone is the current standard of care in first-line chemotherapy for metastatic hormone-refractory prostate cancer. However, there is no agent proven as effective after progression ...